DAFNA Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.11M | Buy |
|
|||||
|
2025
Q1 | $4.91M | Buy |
|
|||||
|
2024
Q4 | $3.79M | Sell |
|
|||||
|
2024
Q3 | $3.93M | Buy |
|
|||||
|
2024
Q2 | $3.86M | Buy |
|
|||||
|
2024
Q1 | $4.37M | Sell |
|
|||||
|
2023
Q4 | $4.44M | Buy |
|
|||||
|
2023
Q3 | $4M | Sell |
|
|||||
|
2023
Q2 | $4.58M | Buy |
|
|||||
|
2023
Q1 | $3.2M | Buy |
|
|||||
|
2022
Q4 | $2.94M | Sell |
|
|||||
|
2022
Q3 | $4.67M | Sell |
|
|||||
|
2022
Q2 | $4.76M | Buy |
|
|||||
|
2022
Q1 | $4.58M | Buy |
|
|||||
|
2021
Q4 | $4.74M | Sell |
|
|||||
|
2021
Q3 | $4.31M | Buy |
|
|||||
|
2021
Q2 | $3.29M | Buy |
|
|||||
|
2021
Q1 | $1.62M | Buy |
|
|||||
|
2020
Q4 | $1.29M | Sell |
|
|||||
|
2020
Q3 | $1.24M | Hold |
|
|||||
|
2020
Q2 | $1.78M | Buy |
|
|||||
|
2020
Q1 | $386K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $116K | Buy |
|